发明名称 |
MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDES |
摘要 |
The present invention provides methods and compositions for treating diseases and pathological conditions or processes mediated by undesired and/or uncontrolled angiongenesis (characterized as "angiogenic diseases") by increasing the in vivo concentration of the A beta peptide, or biologically active fragments or variants of the A beta peptide, within a patient suffering from such diseases, conditions, or processes. The present invention also concerns diagnostic methods and kits for detection and measurement of anti-angiogenic A beta peptide activity in biological fluids and tissues. Such diagnostic methods and kits can be utilized to screen compounds for potential therapeutic activity in the treatment of Alzheimer's disease. |
申请公布号 |
WO03014329(A3) |
申请公布日期 |
2004.02.12 |
申请号 |
WO2002US27040 |
申请日期 |
2002.08.12 |
申请人 |
UNIVERSITY OF SOUTH FLORIDA;PARIS, DANIEL;MULLAN, MICHAEL |
发明人 |
PARIS, DANIEL;MULLAN, MICHAEL |
分类号 |
A61K38/17;G01N33/68 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|